Association of pain and clinical factors on disability and quality of life in systemic sclerosis: A cross-sectional study from Turkish League Against Rheumatism Network
dc.contributor.author | Cevik, Remzi | |
dc.contributor.author | Em, Serda | |
dc.contributor.author | Nas, Kemal | |
dc.contributor.author | Toprak, Murat | |
dc.contributor.author | Cengiz, Gizem | |
dc.contributor.author | Calis, Mustafa | |
dc.contributor.author | Sezer, Ilhan | |
dc.date.accessioned | 2024-02-23T14:40:48Z | |
dc.date.available | 2024-02-23T14:40:48Z | |
dc.date.issued | 2023 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Objectives: In this study, we aimed to evaluate the factors associated with disability and quality of life (QoL) in Turkish patients with systemic sclerosis (SSc). Patients and methods: Between January 2018 and January 2019, a total of 256 SSc patients (20 males, 236 females; mean age: 50.9 +/- 12.4 years; range, 19 to 87 years) who were diagnosed with SSc were included in the study. Disability and health-related QoL (HRQoL) were evaluated by the Health Assessment Questionnaire (HAQ), scleroderma HAQ (SHAQ), Duruoz Hand Index (DHI), and Short Form-36 (SF-36). Linear regression analysis methods were used to describe factors associated with disability and QoL of the patients. Results: All disability scores were higher and HRQoL scores were lower in diffuse cutaneous SSc patients compared limited cutaneous SSc, and differentiations were significant (p= 0.001 and p= 0.007). In multiple regression, pain (VAS) was the strongest predictor for high disability and low QoL scores (p<0.001) as HAQ (beta=0.397, 0.386, 0.452), SHAQ (beta=0.397, 0.448, 0.372), DHI (beta=0.446, 0.536, 0.389), PCS (beta=- 0.417,- 0.499, -0.408) and MCS (beta=-0.478, -0.441, -0.370) in combined, lcSSc and dcSSc patients respectively. The factors associated with high disability and low QoL scores were forced vital capacity for HAQ (beta=- 0.172, p=0.002) and SF-36 PCS (beta= 0.187, p= 0.001); disease duration for HAQ (beta=0.208, p<0.001), DHI (beta=0.147, p=0.006), and SF-36 PCS (beta=-0.134, p= 0.014); 6-minute walk test for HAQ (beta=- 0.161, p= 0.005) and SF-36 PCS (beta= 0.153, p=0.009); and modified Rodnan skin score for SHAQ (beta= 0.250, p<0.001) and DHI (beta=0.233, p<0.001) in SSc patients. Diffusing capacity of the lungs for carbon monoxide for HAQ (beta=- 0.189, p=0.010) and SHAQ (beta=-0.247, p= 0.002); erythrocyte sedimentation rate for DHI (beta=0.322, p<0.001); age for SF-36 PCS (beta=-0.221, p=0.003) and body mass index for SF-36 PCS (beta=-0.200, p=0.008) and MCS (beta=-0.175, p=0.034) were the other variables associated with high disability or low QoL scores in SSc subsets. Conclusion: Clinicians should consider the management of the pain and its sources as a key to improve better functional state and quality of daily life in SSc. | en_US |
dc.identifier.doi | 10.46497/ArchRheumatol.2023.9243 | |
dc.identifier.endpage | 21 | en_US |
dc.identifier.issn | 2618-6500 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 37235112 | en_US |
dc.identifier.scopus | 2-s2.0-85150263701 | en_US |
dc.identifier.startpage | 9 | en_US |
dc.identifier.uri | https://doi.org/10.46497/ArchRheumatol.2023.9243 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/16593 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:001101876400002 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Turkish League Against Rheumatism | en_US |
dc.relation.ispartof | Archives Of Rheumatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Disability | en_US |
dc.subject | Pain | en_US |
dc.subject | Quality Of Life | en_US |
dc.subject | Systemic Sclerosis | en_US |
dc.title | Association of pain and clinical factors on disability and quality of life in systemic sclerosis: A cross-sectional study from Turkish League Against Rheumatism Network | en_US |
dc.type | Article | en_US |